Newsletter | July 31, 2025

07.31.25 -- Nitrosamine Impurity Detection And Quantification In Sartans And Ranitidine

Nitrosamine Impurity Detection And Quantification In Sartans And Ranitidine

Nitrosamine impurities are probable human carcinogens. Discover how GC/MS methods for impurities like N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) helps safeguard pharmaceutical quality and meet evolving global regulatory demands.

 

Flow Chemistry vs. Batch Processes: Exploring Advantages

Continuous flow chemistry can accelerate your chemical development with greater efficiency, safety, and sustainability compared to traditional batch processes. From a chemist's view point, flow chemistry offers two distinct advantages: control and connectivity.

 

Advancing In Silico Predictions In Early Drug Discovery

In drug development, distribution coefficient (LogD) describes the lipophilicity of a drug candidate. Examine a high-throughput approach that streamlines LogD measurements, offering faster and more accurate insight into compound lipophilicity to support better decision-making.

 

SOLUTIONS

Combat Nitrosamine Challenges With Analytical Solutions

At Aragen, our analytical team follows a rigorous three-step approach—risk assessment, confirmatory testing, and remediation planning—to ensure that pharmaceutical products are safe for human use.

• Request Information